Emerging digital health company expands operations to new telehealth services

Client(s) Digital health company

Jones Day advised an emerging digital health company in expanding its telehealth product offerings to patients across the United States and in responding to several state regulator inquiries regarding its operations. Jones Day advised the company with respect to a host of telehealth regulatory and transactional matters including state specific telehealth practice and prescribing standards, professional corporation affiliations, corporate practice of medicine prohibitions, various pharmacy regulatory matters, the supervision and delegation requirements for the use of non-physician providers, and regulatory diligence support for Seed, Series A, and Series B financing rounds.